Evidence map›Paper›PMID 41247633›Full record

ArticleInternational ophthalmology2025

Long-term outcomes of Baerveldt glaucoma implants with the scleral flap and patch technique and vitreous cavity insertion: a 5-year follow-up.

Aya Taniguchi, Naoki Tojo, Akio Miyakoshi, Atsushi Hayashi

Abstract read
PubMed Publisher
In one paragraph

Article in International ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Aya TaniguchiDepartment of Ophthalmology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630, Sugitani, Toyama, 930-0194, Japan.
Naoki TojoDepartment of Ophthalmology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630, Sugitani, Toyama, 930-0194, Japan. tojo2005nm@yahoo.co.jp.ORCID http://orcid.org/0000-0002-8036-4781
Akio MiyakoshiDepartment of Ophthalmology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630, Sugitani, Toyama, 930-0194, Japan.
Atsushi HayashiDepartment of Ophthalmology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630, Sugitani, Toyama, 930-0194, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOur earlier report described the scleral flap and patch technique for a Baerveldt glaucoma implant (BGI). In this procedure, the Hoffman elbow is covered not only with a scleral flap (autograft) but also with a grafted sclera from a donor. This technique is expected to be effective in preventing tube erosion. Herein, we investigated the surgical outcomes of this method. PATIENTS AND

methodsThis was a single-facility retrospective analysis of 120 consecutive patients (140 eyes) who underwent BGI surgery with the scleral flap and patch technique and were followed or > 1 year. We used two criteria for success concerning the patients' postoperative intraocular pressure (IOP) values: IOP ≤ 21 and IOP ≤ 15 mmHg.

resultsThe preoperative IOP was 31.4 ± 9.8 mmHg. BGI surgery significantly decreased the IOP to 11.3 ± 3.6, 11.4 ± 3.9, 12.2 ± 4.4, 12.5 ± 4.2, and 12.2 ± 3.9 mmHg at 1, 2, 3, 4 and 5 years post-surgery (p0.001), respectively. The success rates at 5 years were 83.8% (≤21 mmHg) and 72.1% (≤15 mmHg). There were eight cases in which the patient lost the sense of light. There was no case of tube erosion or hypotony. Bullous keratopathy occurred in three cases. The corneal endothelial cell density (CECD) had changed from 1891 ± 614 to 1882 ± 761 after 5 years (p=0.776).

conclusionsBGI surgery with the scleral flap and patch can effectively prevent tube erosion, hypotony, and CECD loss over a long term.

Indexed as

GlaucomaGlaucoma Drainage ImplantsIntraocular PressureScleraSurgical FlapsAdultAgedAged, 80 and overFemaleFollow-Up StudiesHumansMaleMiddle AgedRetrospective StudiesTime FactorsTreatment OutcomeBaerveldtComplicationCorneal edemaExposureScleraScleral flapVitreous

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.